Literature DB >> 12584492

Connecting bar for hip spica reinforcement: does it help?

Harish S Hosalkar1, Stanley Jones, Moti Chowdhury, Minhal Chatoo, Robert A Hill.   

Abstract

The purpose of this prospective study was to determine if a connecting bar prevented mechanical failure of hip spicas. Eighty-two hip spicas were applied to 70 patients between April 2000 and June 2001 following open or closed reduction for developmental dysplasia of the hip. Bilateral hip surgery was undertaken in 12 patients. Thirty-six spicas were applied with a bar whilst 46 were without. The technique of application was similar in all patients. Overall nine (11%) hip spicas failed (mechanically) prematurely and had to be replaced in hospital under general anaesthesia. All nine were inpatients whose spica did not have a connecting bar (P < 0.005). The rate of spica revision increased with the age of the patient. All parents of failed spica cases (nine cases) preferred the new spica with a bar to the previous one without, because they agreed that the bar made the spica more secure. The bar did not hamper toileting or handling.

Entities:  

Mesh:

Year:  2003        PMID: 12584492     DOI: 10.1097/01.bpb.0000049572.53117.bb

Source DB:  PubMed          Journal:  J Pediatr Orthop B        ISSN: 1060-152X            Impact factor:   1.041


  3 in total

1.  Physical and Clinical Evaluation of Hip Spica Cast applied with Three-slab Technique using Fibreglass Material.

Authors:  K M Bitar; M E Ferdhany; E I Ashraf; A Saw
Journal:  Malays Orthop J       Date:  2016-11

2.  Systematic review of spica casting for the treatment of paediatric diaphyseal femur fractures.

Authors:  R T Tisherman; J S Hoellwarth; S A Mendelson
Journal:  J Child Orthop       Date:  2018-04-01       Impact factor: 1.548

3.  Comparing the mechanical strength of hip spica cast between a conventional and a new method of application.

Authors:  Kwong-Lee Wan; Rukmanikanthan Shanmugam; Kun-Yun Lee; Aik Saw
Journal:  J Child Orthop       Date:  2016-09-10       Impact factor: 1.548

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.